The role of diethylstilbestrol in the treatment of prostate cancer

This publication has 22 references indexed in Scilit:

• Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality
  Urology, 2000
• Experience with low‐dose oestrogen in the treatment of advanced prostate cancer: a personal view
  British Journal of Urology, 1996
• Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.
  Journal of Clinical Oncology, 1996
• The Final Analysis of the EORTC Genito-Urinary T ract Cancer Co-Operative Group Phase III Clinical Trial (Protocol 30805) Comparing Orchidectomy, Orchidectomy plus Cyproterone Acetate and Low Dose Stilboestrol in the Management of Metastatic Carcinoma of the Prostate
  European Urology, 1995
• A Comparison of the Effect of Diethylstilbestrol with Low Dose Estramustine Phosphate in the Treatment of Advanced Prostatic Cancer: Final Analysis of a Phase III Trial of the European Organization for Research on Treatment of Cancer
  Journal of Urology, 1986
• Cardiovascular Side Effects of Diethylstilbestrol, Cyproterone Acetate, Medroxyprogesterone Acetate and Estramustine Phosphate Used for the Treatment of Advanced Prostatic Cancer: Results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762
  Journal of Urology, 1986
• Leuprolide versus Diethylstilbestrol for Metastatic Prostate Cancer
  New England Journal of Medicine, 1984
• Clotting Predisposition in Carcinoma of the Prostate
  Journal of Urology, 1980
• Endocrine changes after diethylstilbestrol therapy Effects on prostatic neoplasm and pituitary-gonadal axis
  Urology, 1976
• Estrogen Dosage and Suppression of Testosterone Levels in Patients with Prostatic Carcinoma
  Journal of Urology, 1973